Type of oncology specialist and treatment-related outcomes in ovarian cancer.
Mark A
MA
Hoffman
Uzma
U
Iqbal
D000465:Algorithms; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006176:Gynecology / Q000379:methods*; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011788:Quality of Life; D012107:Research Design; D018426:SEER Program; D016896:Treatment Outcome
D000970:Antineoplastic Agents